On Monday, September 22, 2025, President Trump announced a policy asserting a link between prenatal acetaminophen (Tylenol) use and autism. Kenvue, the manufacturer of Tylenol, disputes the claim, and leading medical organizations report that current evidence does not establish a causal relationship.
Current clinical guidance supports directed use of acetaminophen (Tylenol) during pregnancy. Clinicians also note that foregoing necessary fever treatment can pose serious health risks.
We expect formal statements from the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics, as well as commentary from major medical journals such as The New England Journal of Medicine and Nature Medicine, soon, and we will share updates on this developing topic as appropriate.
This message is for informational purposes only and does not constitute medical advice. Please consult your healthcare professional for guidance specific to your situation.
UPDATE: On Monday, September 22, the American College of Obstetricians and Gynecologists (ACOG) shared that more than two decades of research have not shown that acetaminophen (Tylenol) in any trimester causes autism or other neurodevelopmental disorders.
On Wednesday, September 24, the World Health Organization (WHO) shared that there is currently no conclusive scientific evidence confirming a possible link between autism and the use of acetaminophen (Tylenol) during pregnancy.
Autism is a neurodevelopmental disability, not a disease, and individualized, strengths-based supports help children and families thrive. Easterseals is dedicated to connecting people with autism and their families with quality services and opportunities so they can live full, meaningful, independent lives.
This message is for informational purposes only and does not constitute medical advice. Please consult your healthcare professional for guidance specific to your situation.
